| The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ... Journal of Thoracic Oncology 11 (1), 39-51, 2016 | 4559 | 2016 |
| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ... The lancet oncology 18 (10), 1373-1385, 2017 | 1069 | 2017 |
| First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial P Baas, A Scherpereel, AK Nowak, N Fujimoto, S Peters, AS Tsao, ... The Lancet 397 (10272), 375-386, 2021 | 1023 | 2021 |
| Modified RECIST criteria for assessment of response in malignant pleural mesothelioma MJ Byrne, AK Nowak Annals of Oncology 15 (2), 257-260, 2004 | 743 | 2004 |
| The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth … WD Travis, H Asamura, AA Bankier, MB Beasley, F Detterbeck, DB Flieder, ... Journal of Thoracic Oncology 11 (8), 1204-1223, 2016 | 688 | 2016 |
| Mesothelin-family proteins and diagnosis of mesothelioma BWS Robinson, J Creaney, R Lake, A Nowak, AW Musk, N de Klerk, ... The Lancet 362 (9396), 1612-1616, 2003 | 672 | 2003 |
| Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells AK Nowak, RA Lake, AL Marzo, B Scott, WR Heath, EJ Collins, ... The Journal of Immunology 170 (10), 4905-4913, 2003 | 544 | 2003 |
| Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors AK Nowak, BWS Robinson, RA Lake Cancer research 63 (15), 4490-4496, 2003 | 516 | 2003 |
| Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled … M Maio, A Scherpereel, L Calabrò, J Aerts, SC Perez, A Bearz, ... The Lancet Oncology 18 (9), 1261-1273, 2017 | 459 | 2017 |
| The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer K Chansky, FC Detterbeck, AG Nicholson, VW Rusch, E Vallières, ... Journal of Thoracic Oncology 12 (7), 1109-1121, 2017 | 457 | 2017 |
| The international association for the study of lung cancer lung cancer staging project: proposals for the revision of the clinical and pathologic staging of small cell lung … AG Nicholson, K Chansky, J Crowley, R Beyruti, K Kubota, A Turrisi, ... Journal of Thoracic Oncology 11 (3), 300-311, 2016 | 426 | 2016 |
| Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3 … MJ van den Bent, B Baumert, SC Erridge, MA Vogelbaum, AK Nowak, ... The Lancet 390 (10103), 1645-1653, 2017 | 416 | 2017 |
| Taxanes for adjuvant treatment of early breast cancer T Ferguson, D Ghersi, AK Nowak, N Wilcken Cochrane database of systematic reviews, 2019 | 355 | 2019 |
| A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma AK Nowak, MJ Byrne, R Williamson, G Ryan, A Segal, D Fielding, ... British journal of cancer 87 (5), 491-496, 2002 | 298 | 2002 |
| Guidelines for the diagnosis and treatment of malignant pleural mesothelioma N Van Zandwijk, C Clarke, D Henderson, AW Musk, K Fong, A Nowak, ... Journal of thoracic disease 5 (6), E254, 2013 | 292 | 2013 |
| Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy AK Nowak, BWS Robinson, RA Lake Cancer research 62 (8), 2353-2358, 2002 | 292 | 2002 |
| Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 … MJ van den Bent, CMS Tesileanu, W Wick, M Sanson, AA Brandes, ... The Lancet Oncology 22 (6), 813-823, 2021 | 276 | 2021 |
| Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target M Jackson, F Hassiotou, A Nowak Carcinogenesis 36 (2), 177-185, 2015 | 265 | 2015 |
| The IASLC lung cancer staging project: background data and proposed criteria to distinguish separate primary lung cancers from metastatic foci in patients with two lung tumors … FC Detterbeck, WA Franklin, AG Nicholson, N Girard, DA Arenberg, ... Journal of Thoracic Oncology 11 (5), 651-665, 2016 | 262 | 2016 |
| Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG … RJ Francis, MJ Byrne, AA Van Der Schaaf, JA Boucek, AK Nowak, ... Journal of Nuclear Medicine 48 (9), 1449-1458, 2007 | 238 | 2007 |
Richard LakeProfessor University of Western AustraliaEmail được xác minh tại uwa.edu.au